Low cytokeratin- and low EpCAM-expressing circulating tumor cells in pancreatic cancer.
Daniel L. Adams(Creatv MicroTech (United States)), Cha‐Mei Tang(Creatv MicroTech (United States)), Susan Tsai(The Ohio State University Wexner Medical Center), О. В. Макарова(Lomonosov Moscow State University), Shuhong Li(Creatv MicroTech (United States)), Peixuan Zhu(Creatv MicroTech (United States)), Platte Amstutz(Creatv MicroTech (United States))
Cited by 3
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism
|EBioMedicine|2017|363
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281